Browsing by Author Mainwaring, Paul

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 8 of 8
Issue DateTitleAuthor(s)Citation
2009Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancerWilcken, Nicholas; Boyle, Frances; Chan, Arlene; Craft, Paul; de Boer, Richard; Mainwaring, Paul; McCarthy, Nicole; Snyder, Raymond; Western Clinical School: Medicine (Westmead)Clinical recommendations for the use of lapatinib ditosylate plus capecitabine for patients with advanced or metastatic HER2-positive breast cancer, Asia Pacific Journal of Clinical Oncology, vol.5, 1,pp 4-16
2004The immune response to breast cancer, and the case for DC immunotherapyHart, Derek; Allan, C; Mainwaring, Paul; Pyke, C; Turtle, Cameron J.; Concord Clinical School: ANZAC Research InstituteThe immune response to breast cancer, and the case for DC immunotherapy, Cytotherapy, vol.6, 2,pp 154-163
2014Multidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practiceWoo, Henry; Begbie, Stephen; Davis, Ian D; Gogna, N Kumar; Mainwaring, Paul; Murphy, Declan; Parnis, Francis; Steer, Christopher; SAHCS: SurgeryMultidisciplinary consensus: A practical guide for the integration of abiraterone into clinical practice, Asia-Pacific Journal of Clinical Oncology, vol.10, 3, 2014,pp 228-236
2009A Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic MelanomaKefford, Richard (Rick); Dar, Mohammed; Kathman, Steven; Kirkwood, John M; Laubscher, Kevin; Logan, Theodore F.; Mainwaring, Paul; Millward, Michael; Pavlick, Anna C.; Tarhini, Ahmad; Western Clinical School: Westmead Millennium InstituteA Phase 2, Randomized Study of SB-485232, rhIL-18, in Patients With Previously Untreated Metastatic Melanoma, Cancer, vol.115, 4,pp 859-868
2009Phase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal CancerClarke, Stephen; Ackland, Stephen P.; Chiara, S.; Gapski, John; Langer, Bernd; Mainwaring, Paul; Perez-Carrion, Ramon; Sobrero, Alberto; Young, Scott; Concord Clinical School: ANZAC Research InstitutePhase IV Study of Bevacizumab in Combination with Infusional Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in First-Line Metastatic Colorectal Cancer, Oncology, vol.77, 2,pp 113-119
2014Systemic treatment of HER2-positive metastatic breast cancer: A systematic reviewWilcken, Nicholas; Beith, Jane; Bell, Richard; Chirgwin, Jacquie; Chua, Sue; Colosimo, Maree; de Boer, Richard; Francis, Prudence; Green, Michael; Mainwaring, Paul; Pittman, K; Snyder, Raymond; White, Michelle; Zdenkowski, Nicholas; Western Clinical School: Medicine (Westmead)Systemic treatment of HER2-positive metastatic breast cancer: A systematic review, Asia-Pacific Journal of Clinical Oncology, vol.10, S4, 2014,pp 1-14
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165
2014Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized studyHarnett, Paul; Bidziński, Mariusz; Blagden, Sarah; Del Prete, Salvatore; Fotopoulou, Christina; Gabra, Hani; Ghamande, Sharad; Gore, Martin; Green, John; Kaye, Stan; Ledermann, Jonathan; Mainwaring, Paul; Spaczyński, Marek; Vergote, Ignace; Vermorken, Jan; Western Clinical School: Medicine (Westmead)Weekly AUC2 carboplatin in acquired platinum-resistant ovarian cancer with or without oral phenoxodiol, a sensitizer of platinum cytotoxicity: the phase III OVATURE multicenter randomized study, Annals of Oncology, vol.25, 1, 2014,pp 160-165